AOP Orphan

Related by string. * AOPs . Ad Ops : Online Publishers AOP . Worldwide AOP . AOP Worldwide . AOP / Orphaned . orphaned . orphans . Orphans . orphaning . ORPHAN . orphan . ORPHANS . ORPHANED : Little Orphan Annie . Swedish Orphan Biovitrum . widows orphans . Orphan Drug Designation . Orphan Drug designation . FDA Orphan Drug . Malawi orphans . Haitian orphans . Haitian Orphans * AOP Orphan Pharmaceuticals *

Related by context. Frequent words. (Click for all words.) 61 Virulizin R 60 Allovectin 7 R 59 ALN RSV# 59 registrational 58 deforolimus 58 IR BioSciences Holdings 57 KNS # 57 ATryn ® 57 Rhucin ® 57 IND enabling 56 ATryn R 56 talactoferrin 56 Cethrin 56 confirmatory Phase III 56 MOZOBIL 56 Marketing Authorization Application 55 Omigard 55 CoFactor 55 IND submission 55 Pivotal Phase III 55 TOCOSOL Paclitaxel 55 humanized anti 55 Cloretazine R VNP#M 55 CR# vcMMAE 54 Pivotal Trial 54 relapsed refractory multiple myeloma 54 BLA submission 54 Amigal 54 BCX# 54 oral calcitonin 54 ComfortScan system 54 DAVANAT ® 54 thymalfasin 54 HCV protease inhibitor 54 CA4P 54 Icatibant 54 registrational trial 54 ONCONASE 54 RHUCIN 54 TELCYTA 53 Orphan Drug status 53 Phenoptin 53 Neuradiab 53 Imprime PGG 53 methylnaltrexone 53 TORISEL 53 FavId 53 BAY #-# 53 romidepsin 53 pralatrexate 53 anticancer compound 53 Azedra 53 Phase III pivotal 53 ridaforolimus 53 TG# [001] 53 teduglutide 53 Marketing Authorization Application MAA 53 Phase 1b trial 53 velaglucerase alfa 52 Phase 2a trial 52 PharmaMar 52 phase IIa 52 Clevudine 52 pseudobulbar affect PBA 52 PROPEL trial 52 Genasense R oblimersen 52 NEBIDO 52 tanespimycin 52 Phase 2a clinical 52 Phase IIa trial 52 relapsed multiple myeloma 52 Phase III Clinical Trial 52 Anthim 52 hepatitis C HCV 52 Investigational Device Exemption IDE 52 MGCD# [001] 52 Nexavar ® 52 Tolerx 51 Orphan Drug Status 51 Phase III clinical 51 Phase III clinical trials 51 IV melanoma 51 alvimopan 51 NEUMUNE 51 Phase Ib 51 Sym# 51 SILENOR TM 51 Pharmion Corporation 51 GammaCan 51 Phase 2b clinical 51 therapeutic monoclonal antibodies 51 ZYBRESTAT 51 Phase 2b trial 51 DAVANAT R 51 sodium Injection 51 TREANDA 51 Biologics License Application 51 Stemedica 51 Asentar 51 drug conjugate 51 Zerenex

Back to home page